In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australian panel consults on increasing transparency at TGA

This article was originally published in RAJ Devices

Executive Summary

The committee that is reviewing the way in which Australia's Therapeutic Goods Administration communicates its regulatory processes and decisions to stakeholders is inviting feedback on how information about the agency's functioning can be better conveyed1.

You may also be interested in...

UK MHRA Explains Procedures For On-Site Inspections In COVID-19 Context

New guidance explains how UK-based sites and organizations can facilitate routine on-site good practice inspections that are due to restart next month.

Canada Asks Insulin Makers To Rectify Inconsistent Product Monographs

A class review of Canadian product monographs for various insulin products has revealed inconsistencies.

Australia Moves To Further Improve Advertising Framework

A review of therapeutic goods advertising reforms that were introduced in Australia in 2018 calls for further changes to support implementation and compliance.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts